Skip to Content
  • 3.4
    Impact Factor
  • 4.6
    CiteScore
  • 26 days
    Submission to First Decision
  • 6 days
    Acceptance to Publication

Dentistry Journal

Dentistry Journal is an international, peer-reviewed, open access journal on dentistry, published monthly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, ESCI (Web of Science), PubMed, PMC, and other databases.
  • Journal Rank: JCR - Q1 (Dentistry, Oral Surgery and Medicine) / CiteScore - Q1 (General Dentistry).
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 25.7 days after submission; acceptance to publication is undertaken in 5.9 days (median values for papers published in this journal in the first half of 2026).
  • Recognition of Reviewers: Reviewers whose reports are timely and of high quality receive an APC discount voucher for a future publication in an MDPI journal. Become a reviewer.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (2,922)

  • Systematic Review
  • Open Access

Background/Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a serious and detrimental condition affecting the jaw bones observed in patients receiving anti-resorptive therapy. The main aim of this systematic review was to identify the potential local risk factors and systemic co-morbidities that can contribute to the development of MRONJ. Methods: A systematic literature search was conducted in PubMed (via Ovid), Web of Science, and Scopus. Predefined inclusion and exclusion criteria were applied, and data were extracted from eligible studies on demographic characteristics, antiresorptive medications, underlying conditions, systemic comorbidities, local dental factors, anatomical distribution, and MRONJ stage. Results: Of 1899 records identified, 233 studies published between 2005 and 2024 met the eligibility criteria. Across these studies, 43,061 patients with MRONJ were reported, predominantly from developed countries. The mean age was 67.2 years (SD, 9.9), and 27,202 (63.2%) were female. Zoledronic acid was the most frequently reported antiresorptive medication (18,656; 43.2%), followed by pamidronate (6133; 14.2%) and denosumab (1923; 4.5%). Cancer was the most frequently reported underlying condition (19,237; 44.6%), followed by osteoporosis/osteopenia (10,806; 25.1%). Among cancer types, breast cancer (6286; 14.5%), multiple myeloma (4112; 9.5%), prostate cancer (3473; 8.1%), and oral cancer (2020; 4.6%) were the most frequently reported. Reported systemic comorbidities included hypertension (3188; 53.6%), chemotherapy (1562; 48.0%), smoking (936; 25.4%), anaemia (1066; 21.8%), diabetes mellitus (964; 19.6%), alcohol consumption (322; 19.2%), and rheumatoid arthritis (563; 9.5%), while radiotherapy was reported in 137 patients (38.0%) across six studies. Reported local dental factors included tooth extraction (5029; 47%), periodontal disease (3381; 46%), periapical infection (189; 37%), denture use (1728; 21.8%), dental abscess (50; 16.5%), dental caries (113; 15.9%), and dental implants (597; 15.4%). MRONJ lesions mostly involved the mandible (8952; 65.4%). Stage 2 MRONJ was most frequently reported (6620; 58.8%), followed by Stage 1 (2483; 22.0%) and Stage 3 (2037; 18.0%). Conclusions: This study provides a comprehensive overview of the related potential risks factors and co-morbid conditions associated with MRONJ. MRONJ predominantly affected older females, with cancer and osteoporosis/osteopenia requiring tooth removal. Zoledronic acid was the most commonly reported antiresorptive medication, while the mandible and Stage 2 MRONJ were most frequently reported. Further high-quality studies are needed to clarify the relative importance of individual risk factors to better guide prevention and management strategies in at-risk patients.

Dent. J.

22 November 2026

PRISMA flow chart of literature search [20].
  • Review
  • Open Access

Background: Bulk-fill resin composites allow placement in thicker increments, but adequate polymerization depends on effective light transmission and appropriate irradiation. Differences in light-curing unit (LCU) spectral emission, irradiance, exposure time, curing mode, and tip-to-restoration distance may influence their polymerization and subsequent properties. This review aimed to evaluate the influence of different light-curing protocols on the performance of bulk-fill resin composites. Methods: The available literature investigating light curing of bulk-fill resin composites was reviewed, with emphasis on LCU characteristics and irradiation parameters. Outcomes included degree of conversion, hardness, depth of cure, mechanical properties, optical behavior, interfacial adaptation, and clinical performance. Sixteen studies meeting the review criteria were analyzed. Results: Most studies focused on laboratory measures of polymerization efficiency, particularly degree of conversion and hardness. Overall, adequate polymerization depended on both material composition and irradiation conditions. Polywave LCUs provided advantages for some composites containing multiple photoinitiators, whereas monowave and polywave units produced comparable results for other materials. Increased curing distance generally impaired polymerization, while the effectiveness of short, high-irradiance protocols was material-dependent and did not consistently reproduce the performance achieved with manufacturer-recommended exposure times. Optical properties, light transmission, mechanical behavior, and interfacial adaptation were likewise influenced by material-specific characteristics and curing conditions. Conclusions: No single light-curing protocol can be considered universally optimal for bulk-fill resin composites. Curing effectiveness reflects the interaction between LCU spectral and energy characteristics, irradiation parameters, restoration geometry, and composite formulation. Standardized laboratory methodologies and long-term clinical studies are needed to establish clinically relevant evidence-based curing protocols.

Dent. J.

22 November 2026

PRISMA flow diagram.
  • Article
  • Open Access

Background/Objectives: Panoramic radiography is the first-line examination before mandibular third molar extraction, but two-dimensional imaging may limit assessment of root proximity to the inferior alveolar canal. This study assessed panoramic risk signs for identifying root–inferior alveolar canal (IAC) contact, using cone-beam computed tomography (CBCT) as the reference standard, and evaluated a selective CBCT referral approach. Methods: This retrospective cross-sectional diagnostic study included 86 mandibular third molars from 62 patients. Four examiners with different clinical experience independently assessed panoramic radiographs for established risk signs. CBCT confirmed root–IAC contact and measured the minimum root–IAC distance. Interobserver agreement, regression analyses, ROC-based diagnostic performance, and an exploratory selective CBCT referral framework were assessed. Results: Root darkening and cortical interruption were the most frequent signs. Interobserver agreement for panoramic signs was generally low, although higher between the most experienced examiners. CBCT measurement reliability was moderate for vertical canal dimensions and root–IAC distance, but poor for transverse canal dimensions. Cortical interruption was the only sign significantly associated with CBCT-confirmed root–IAC contact. Panoramic radiography underestimated the root–IAC distance. The selective framework would have recommended CBCT in 33/86 molars (38.4%) and identified 33/38 confirmed contacts (86.8%). Conclusions: Cortical interruption appears to be the most clinically relevant panoramic sign for identifying mandibular third molars that may benefit from additional three-dimensional anatomical assessment. Structured criteria and senior review in borderline cases may support radiation justification and avoid routine CBCT use.

Dent. J.

22 November 2026

Representative panoramic radiographic risk signs assessed in the study: (a) Root darkening. (b) Interruption of the superior cortical outline of the mandibular canal. (c) Canal narrowing. (d) Canal deviation. (e) Root narrowing. (f) Root deflection. (g) Bifid apex. (h) Island-shaped apex. Arrows indicate the apical root region of the mandibular third molar where the radiographic feature of interest is observed.
  • Review
  • Open Access

Pharmacovigilance in Dental Practice: A Scoping Review

  • Maria Inês Guimarães,
  • Madalena Silva and
  • Inês Lopes Cardoso
  • + 2 authors

Background/Objectives: Dental practice relies heavily on the prescription of medications such as Nonsteroidal Anti-inflammatory Drugs, local anesthetics, antibiotics, and antiresorptive agents. Although generally considered safe, these medications may be associated with adverse drug reactions capable of compromising patient safety and influencing clinical decision-making. This scoping review aimed to map and synthesize the available evidence regarding adverse drug reactions associated with dental clinical practice. Methods: The review was conducted in accordance with the Joanna Briggs Institute methodology and the PRISMA-ScR guidelines. Searches of the PubMed, ScienceDirect, and CI-NAHL databases identified 1731 records and 15 identified by citation searching, of which 19 studies met the predefined eligibility criteria. Results: The findings revealed marked differences in adverse drug reactions profiles across pharmacological groups. Nonsteroidal Anti-inflammatory Drugs were associated with rare but potentially severe mucocutaneous reactions, including erythema multiforme. Local anesthetics demonstrated an extremely low incidence of true allergic reactions, with most adverse events being psychogenic or related to excipients within the anesthetic formulation. Antibiotics, particularly clindamycin, were linked to the highest burden of severe and fatal adverse drug reactions, while inaccurate penicillin allergy labelling emerged as a clinically significant challenge with implications for antimicrobial stewardship and patient outcomes. Antiresorptive and immunomodulatory therapies were primarily associated with medication-related osteonecrosis of the jaw, one of the most serious medication-related complications encountered in dental practice. Across all pharmacological groups, underreporting of adverse drug reactions emerged as a persistent obstacle to effective pharmacovigilance and early safety signal detection. Conclusions: Overall, this review highlights adverse drug reactions as an important yet underrecognized component of dental practice. The findings emphasize the need for evidence-informed prescribing, improved recognition and reporting of adverse drug reactions, and stronger integration of pharmacovigilance into routine dental care to enhance patient safety and optimize therapeutic outcomes.

Dent. J.

21 November 2026

Flowchart of article selection process, adapted from PRISMA 2000 flow diagram [21].

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Dent. J. - ISSN 2304-6767